Table of Contents

company-logo

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Longboard Pharmaceuticals Dividend Announcement

• Longboard Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Longboard Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Longboard Pharmaceuticals Dividend History

Longboard Pharmaceuticals Dividend Yield

Longboard Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Longboard Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Longboard Pharmaceuticals Financial Ratios

P/E ratio-30499.99
PEG ratio1601.25
P/B ratio8461.52
ROE-33.03%
Payout ratio0.00%
Current ratio15.97
Quick ratio15.97
Cash Ratio1.50

Longboard Pharmaceuticals Dividend FAQ

Does Longboard Pharmaceuticals stock pay dividends?
Longboard Pharmaceuticals does not currently pay dividends to its shareholders.
Has Longboard Pharmaceuticals ever paid a dividend?
No, Longboard Pharmaceuticals has no a history of paying dividends to its shareholders. Longboard Pharmaceuticals is not known for its dividend payments.
Why doesn't Longboard Pharmaceuticals pay dividends?
There are several potential reasons why Longboard Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Longboard Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Longboard Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Longboard Pharmaceuticals a dividend aristocrat?
Longboard Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Longboard Pharmaceuticals a dividend king?
Longboard Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Longboard Pharmaceuticals a dividend stock?
No, Longboard Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Longboard Pharmaceuticals stocks?
To buy Longboard Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Longboard Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.